News Channels

04 May 2018 Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer
04 May 2018 Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
03 May 2018 Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies
03 May 2018 Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer Patients
03 May 2018 Eidos Therapeutics Initiates Phase 2 Clinical Trial for AG10 Targeting Transthyretin Amyloidosis Cardiomyopathy
03 May 2018 Sylentis Announces the Clinical Results of Tivanisiran for the Treatment of Dry Eye Syndrome
03 May 2018 Coherus BioSciences Re-Submits Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate)
03 May 2018 European Medicines Agency Validates Bristol-Myers Squibb’s Type II Variation Application for Opdivo Plus Yervoy Combination for Treatment of First-Line Metastatic Non-Small Cell Lung Cancer (NSCLC)
03 May 2018 Merck Provides Update on KEYNOTE-407 Trial
03 May 2018 Esperion Announces Positive Top-Line Results from Pivotal Phase 3 Long-Term Safety Study of Bempedoic Acid
03 May 2018 Cellectis Files IND for UCART22 in Acute Lymphoblastic Leukemia (B-ALL)
03 May 2018 miRagen Therapeutics Presents New Preclinical Data Supporting use of MicroRNA-Targeted Therapies for Ophthalmic Diseases
03 May 2018 Sandoz receives complete response letter from the US FDA for proposed biosimilar rituximab
03 May 2018 FDA updates Trintellix® (vortioxetine) label to include data showing improvement in processing speed, an important aspect of cognitive function in acute Major Depressive Disorder (MDD)
03 May 2018 Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections
03 May 2018 New data from Biotest's monoclonal antibody-drug-conjugate (ADC) BT-062 in the therapy of solid tumors
02 May 2018 Bactevo Enters Drug Discovery Agreement with Boehringer Ingelheim
02 May 2018 NeoImmuneTech Announces a Clinical Trial Collaboration with a Global Leading Pharmaceutical Company to Evaluate HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
02 May 2018 Bioniz Therapeutics Announces Positive Phase 1b Clinical Study Results for Investigational Agent BNZ-1
02 May 2018 Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up